Literature DB >> 22044575

Neutrophil extracellular traps promote deep vein thrombosis in mice.

A Brill1, T A Fuchs, A S Savchenko, G M Thomas, K Martinod, S F De Meyer, A A Bhandari, Denisa D Wagner.   

Abstract

BACKGROUND: Upon activation, neutrophils can release nuclear material known as neutrophil extracellular traps (NETs), which were initially described as a part of antimicrobial defense. Extracellular chromatin was recently reported to be prothrombotic in vitro and to accumulate in plasma and thrombi of baboons with experimental deep vein thrombosis (DVT).
OBJECTIVE: To explore the source and role of extracellular chromatin in DVT.
METHODS: We used an established murine model of DVT induced by flow restriction (stenosis) in the inferior vena cava (IVC).
RESULTS: We demonstrate that the levels of extracellular DNA increase in plasma after 6 h IVC stenosis, compared with sham-operated mice. Immunohistochemical staining revealed the presence of Gr-1-positive neutrophils in both red (RBC-rich) and white (platelet-rich) parts of thrombi. Citrullinated histone H3 (CitH3), an element of NETs' structure, was present only in the red part of thrombi and was frequently associated with the Gr-1 antigen. Immunofluorescent staining of thrombi showed proximity of extracellular CitH3 and von Willebrand factor (VWF), a platelet adhesion molecule crucial for thrombus development in this model. Infusion of Deoxyribonuclease 1 (DNase 1) protected mice from DVT after 6 h and also 48 h IVC stenosis. Infusion of an unfractionated mixture of calf thymus histones increased plasma VWF and promoted DVT early after stenosis application.
CONCLUSIONS: Extracellular chromatin, likely originating from neutrophils, is a structural part of a venous thrombus and both the DNA scaffold and histones appear to contribute to the pathogenesis of DVT in mice. NETs may provide new targets for DVT drug development.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22044575      PMCID: PMC3319651          DOI: 10.1111/j.1538-7836.2011.04544.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  42 in total

Review 1.  Cell biology of von Willebrand factor.

Authors:  D D Wagner
Journal:  Annu Rev Cell Biol       Date:  1990

2.  Histone-induced damage of a mammalian epithelium: the role of protein and membrane structure.

Authors:  T J Kleine; P N Lewis; S A Lewis
Journal:  Am J Physiol       Date:  1997-12

3.  Histones and basic polypeptides activate Ca2+/cation influx in various cell types.

Authors:  A Gamberucci; R Fulceri; P Marcolongo; W F Pralong; A Benedetti
Journal:  Biochem J       Date:  1998-04-15       Impact factor: 3.857

4.  Binding of the von Willebrand factor A1 domain to histone.

Authors:  C M Ward; T J Tetaz; R K Andrews; M C Berndt
Journal:  Thromb Res       Date:  1997-06-15       Impact factor: 3.944

5.  Induction of neutrophil extracellular DNA lattices by placental microparticles and IL-8 and their presence in preeclampsia.

Authors:  Anurag Kumar Gupta; Paul Hasler; Wolfgang Holzgreve; Stefan Gebhardt; Sinuhe Hahn
Journal:  Hum Immunol       Date:  2006-01-04       Impact factor: 2.850

6.  Activated platelets induce Weibel-Palade-body secretion and leukocyte rolling in vivo: role of P-selectin.

Authors:  Vandana S Dole; Wolfgang Bergmeier; Heather A Mitchell; Sarah C Eichenberger; Denisa D Wagner
Journal:  Blood       Date:  2005-06-14       Impact factor: 22.113

Review 7.  Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia.

Authors:  Robert D Guzy; Paul T Schumacker
Journal:  Exp Physiol       Date:  2006-07-20       Impact factor: 2.969

8.  Development and maturation of thymic dendritic cells during human ontogeny.

Authors:  Alexander S Savchenko; Go Hasegawa; Makoto Naito
Journal:  Cell Tissue Res       Date:  2006-05-03       Impact factor: 5.249

9.  Mutation in blood coagulation factor V associated with resistance to activated protein C.

Authors:  R M Bertina; B P Koeleman; T Koster; F R Rosendaal; R J Dirven; H de Ronde; P A van der Velden; P H Reitsma
Journal:  Nature       Date:  1994-05-05       Impact factor: 49.962

10.  Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.

Authors:  B Dahlbäck; M Carlsson; P J Svensson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

View more
  329 in total

1.  Dynamic pathology for circulating free DNA in a dextran sodium sulfate colitis mouse model.

Authors:  Yuhki Koike; Keiichi Uchida; Koji Tanaka; Shozo Ide; Kohei Otake; Yoshiki Okita; Mikihiro Inoue; Toshimitsu Araki; Akira Mizoguchi; Masato Kusunoki
Journal:  Pediatr Surg Int       Date:  2014-11-04       Impact factor: 1.827

2.  Von Willebrand factor is reversibly decreased during torpor in 13-lined ground squirrels.

Authors:  Scott Cooper; Shawn Sell; Luke Nelson; Jennifer Hawes; Jacob A Benrud; Bridget M Kohlnhofer; Bradley R Burmeister; Veronica H Flood
Journal:  J Comp Physiol B       Date:  2016-01       Impact factor: 2.200

3.  Neutrophil extracellular traps in COVID-19.

Authors:  Yu Zuo; Srilakshmi Yalavarthi; Hui Shi; Kelsey Gockman; Melanie Zuo; Jacqueline A Madison; Christopher Blair; Andrew Weber; Betsy J Barnes; Mikala Egeblad; Robert J Woods; Yogendra Kanthi; Jason S Knight
Journal:  JCI Insight       Date:  2020-06-04

Review 4.  New insights into modulation of thrombin formation.

Authors:  Henri M H Spronk; Julian I Borissoff; Hugo ten Cate
Journal:  Curr Atheroscler Rep       Date:  2013-11       Impact factor: 5.113

Review 5.  Animal models of venous thrombosis.

Authors:  Hassan Albadawi; Avery A Witting; Yash Pershad; Alex Wallace; Andrew R Fleck; Peter Hoang; Ali Khademhosseini; Rahmi Oklu
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

6.  [Prevention of recurrent thromboembolisms: WARFASA (aspirin for the prevention of recurrent venous thromboembolism - the Warfarin and Aspirin Study)].

Authors:  D Duerschmied; S Nitschmann; C Bode
Journal:  Internist (Berl)       Date:  2013-11       Impact factor: 0.743

7.  In Vivo Role of Neutrophil Extracellular Traps in Antiphospholipid Antibody-Mediated Venous Thrombosis.

Authors:  He Meng; Srilakshmi Yalavarthi; Yogendra Kanthi; Levi F Mazza; Megan A Elfline; Catherine E Luke; David J Pinsky; Peter K Henke; Jason S Knight
Journal:  Arthritis Rheumatol       Date:  2017-03       Impact factor: 10.995

8.  Neutrophil extracellular traps are pathogenic in primary graft dysfunction after lung transplantation.

Authors:  David M Sayah; Beñat Mallavia; Fengchun Liu; Guadalupe Ortiz-Muñoz; Axelle Caudrillier; Ariss DerHovanessian; David J Ross; Joseph P Lynch; Rajan Saggar; Abbas Ardehali; Lorraine B Ware; Jason D Christie; John A Belperio; Mark R Looney
Journal:  Am J Respir Crit Care Med       Date:  2015-02-15       Impact factor: 21.405

9.  Disulfide HMGB1 derived from platelets coordinates venous thrombosis in mice.

Authors:  Konstantin Stark; Vanessa Philippi; Sven Stockhausen; Johanna Busse; Antonella Antonelli; Meike Miller; Irene Schubert; Parandis Hoseinpour; Sue Chandraratne; Marie-Luise von Brühl; Florian Gaertner; Michael Lorenz; Alessandra Agresti; Raffaele Coletti; Daniel J Antoine; Ralf Heermann; Kirsten Jung; Sven Reese; Iina Laitinen; Markus Schwaiger; Axel Walch; Markus Sperandio; Peter P Nawroth; Christoph Reinhardt; Sven Jäckel; Marco E Bianchi; Steffen Massberg
Journal:  Blood       Date:  2016-08-29       Impact factor: 22.113

Review 10.  Thrombosis as an intravascular effector of innate immunity.

Authors:  Bernd Engelmann; Steffen Massberg
Journal:  Nat Rev Immunol       Date:  2012-12-07       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.